The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric in elderly men

Journal of Human Genetics

Volumn 45, Issue 4, 2000, Pages 257-262

  Zuo, Ming ^a   Nishio, Hisahide ^a   Lee, Myeong Jin ^a   Maejima, Kenji ^b   Mimura, Sigenobu ^b   Sumino, Kimiaki ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hyogo Health Service Association   (Japan)

Author keywords

Homocysteine; MTHFR; Uric acid

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; HOMOCYSTEINE; URIC ACID;

ADULT; AGED; ARTICLE; ENZYME ACTIVITY; GENE; GENE MUTATION; GENOTYPE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 0033928273     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380070037     Document Type: Article

References (31)

1. Akaoka I, Fujimori S, Kamatani N, Takeuchi F, Yano E, Nishida Y, Hashimoto A, Horiuchi Y (1981) A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme. J Rheumatol 8:563-574
2. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T (1989) Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 79:139-146
3. Brand FN, McGee DL, Kannel WB, Stokes JD, Castelli WP (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 121:11-18
4. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, Genest J Jr, Rozen R (1997) Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vase Biol 17:569-573
5. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P (1990) Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21:572-576
6. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7-13
7. Emmerson BT, Nagel SL, Duffy DL, Martin NG (1992) Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 51:375-377
8. Evers S, Koch HG, Grotemeyer KH, Lange B, Deufel T, Ringelstein EB (1997) Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. Arch Neurol 54:1276-1282
9. Freedman DS, Williamson DF, Gunter EW, Byers T (1995) Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 141:637-644
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
11. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 136:347-354
12. Kang SS, Wong PW, Cook HY, Norusis M, Messer JV (1986) Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 77:1482-1486
13. Lehto S, Niskanen L, Rönnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29:635-639
14. Malinow MR (1994) Homocyst(e)ine and arterial occlusive diseases. J Intern Med 236:603-617
15. Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, Simon A (1995) Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 114:175-183
16. Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Kitamura K, Yazaki Y (1998) Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vase Biol 18:1465-1469
17. Motti C, Gnasso A, Bernardini S, Massoud R, Pastore A, Rampa P, Federici G, Cortese C (1998) Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 139:377-383
18. Nishio H, Lee MJ, Fujii M, Kario K, Kayaba K, Shimada K, Matsuo M, Sumino K (1996) A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn J Hum Genet 41:247-251
19. Okada M, Ueda K, Omae T, Takeshita M, Hirota Y (1982) The relationship of serum uric acid to hypertension and ischemic heart disease in Hisayama population, Japan. J Chronic Dis 35:173-178
20. Ou T, Yamakawa-Kobayashi K, Arinami T, Amemiya H, Fujiwara H, Kawata K, Saito M, Kikuchi S, Noguchi Y, Sugishita Y, Hamaguchi H (1998) Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis 137: 23-28
21. Persky VW, Dyer AR, Stamler J, Idris-soven E, Shekelle RB, Schoenberger JA, Berkson DM, Lindberg HA (1979) Uric acid: a risk factor for coronary heart disease? Circulation 59:969-977
22. Reed D, Labarthe D, Stallones R (1972) Epidemiologic studies of serum uric acid levels among Micronesians. Arthritis Rheum 15:381-390
23. Scott J, Weir D (1996) Homocysteine and cardiovascular disease. Q J Med 89:561-563
24. Seegmiller JE, Rosenbloom FM, Kelley WN (1967) Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155:1682-1684
25. Sperling O, Persky-Brosh S, Boer P, De Vries A (1973) Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties. Biochem Med 7:389-395
26. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H (1988) Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 127:321-336
27. van der Put NMJ, Steegers-Theunissen RP, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071
28. van der Put NMJ, van den Heuvel LP, Steegers-Theunissen RP, Trijbels FJM, Eskes TKAB, Mariman ECM, den Heyer M, Blom HJ (1996) Decreased methylene tetrahydrofolate reductase activity due to the 677C→T mutation in families with spina bifida offspring. J Mol Med 74:691-694
29. van der Put NMJ, Gabreels F, Stevens EMB, Smeitink JA, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051
30. Wannamethee SG, Shaper AG, Whincup PH (1997) Serum urate and the risk of major coronary heart disease events. Heart 78:147-153
31. Whitfield JB, Martin NG (1983) Inheritance and alcohol as factors influencing plasma uric acid levels. Acta Genet Med Gemellol Roma 32:117-126